BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹106 Cr | ₹103 Cr | ₹34 Cr | ₹135 Cr | ₹64 Cr |
What is the latest Cash Flow from Operating Activities ratio of BLISS GVS PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹106 Cr |
| Mar2024 | ₹103 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹135 Cr |
| Mar2021 | ₹64 Cr |
How is Cash Flow from Operating Activities of BLISS GVS PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹106 Cr | 3.01 | |
| Mar2024 | ₹103 Cr | 199.64 | |
| Mar2023 | ₹34 Cr | -74.67 | |
| Mar2022 | ₹135 Cr | 111.79 | |
| Mar2021 | ₹64 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,507.5 Cr | 8.2% | 10.9% | 96.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 8.2% |
10.9% |
96.2% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses